1. CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer
    Pan Hu et al, 2023, Mediators of Inflammation CrossRef
  2. The Role of Tight Junction Proteins in Cancer
    Jayaprakash Narayana Kolla et al, 2023, Tight Junctions in Inflammation and Cancer CrossRef
  3. Research progress on the mechanism of radiation enteritis
    Jinjia Fan et al, 2022, Frontiers in Oncology CrossRef
  4. CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer
    Huinan Qu et al, 2021, International Journal of Molecular Sciences CrossRef
  5. Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism
    Sanyog Dwivedi et al, 2022, International Journal of Molecular Sciences CrossRef
  6. The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis
    Adrian Georg Simon et al, 2023, Journal of Translational Medicine CrossRef
  7. Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma
    Xu Zhang et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
  8. Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors
    Qiuqiang Chen et al, 2022, Cancers CrossRef
  9. Genome analysis reveals hepatic transcriptional reprogramming changes mediated by enhancers during chick embryonic development
    Xi Sun et al, 2023, Poultry Science CrossRef
  10. Chimeric antigen receptor engineered natural killer cells for cancer therapy
    Yalan Zhang et al, 2023, Experimental Hematology & Oncology CrossRef
  11. The Roles of Tricellular Tight Junction Protein Angulin-1/Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Endometriosis and Endometrioid-Endometrial Carcinoma
    Hiroshi Shimada et al, 2021, Cancers CrossRef
  12. Claudin and pancreatic cancer
    Chen Wang et al, 2023, Frontiers in Oncology CrossRef
  13. Claudins—Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies?
    Marta Łukaszewicz-Zając et al, 2023, Cancers CrossRef
  14. Binding of YY1/CREB to an Enhancer Region Triggers Claudin 6 Expression in H. pylori LPS-Stimulated AGS Cells
    Jorge H. Romero-Estrada et al, 2023, International Journal of Molecular Sciences CrossRef
  15. Knockdown of CLAUDIN-6 Inhibited Apoptosis and Induced Proliferation of Bovine Cumulus Cells
    Wanjie Wang et al, 2022, International Journal of Molecular Sciences CrossRef
  16. Vaccine Boosting CAR-T Cell Therapy: Current and Future Strategies
    Emmanuel Owusu Ansah et al, 2023, Advances in Cell and Gene Therapy CrossRef
  17. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
    Andreas Mackensen et al, 2023, Nature Medicine CrossRef